Skip to main content

Market Overview

Abbott Laboratories: Q4 Earnings Insights



Shares of Abbott Laboratories (NYSE:ABT) moved lower by 0.8% in pre-market trading after the company reported Q4 results.

Quarterly Results

Earnings per share increased 52.63% year over year to $1.45, which beat the estimate of $1.35.

Revenue of $10,701,000,000 up by 28.71% year over year, which beat the estimate of $9,940,000,000.


Abbott said it sees FY21 adjusted EPS of at least $5.00. 

Details Of The Call

Date: Jan 27, 2021

Time: 09:00 AM

ET Webcast URL:


Company's 52-week high was at $115.40

Company's 52-week low was at $61.61

Price action over last quarter: Up 5.18%

Company Description

Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.


Related Articles (ABT)

View Comments and Join the Discussion!

Posted-In: BZI-RecapsEarnings News

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at